2. Academic Validation
  3. Structure-based optimization of a potent class of arylamide FMS inhibitors

Structure-based optimization of a potent class of arylamide FMS inhibitors

  • Bioorg Med Chem Lett. 2008 Jun 15;18(12):3632-7. doi: 10.1016/j.bmcl.2008.04.059.
Sanath K Meegalla 1,  Mark J Wall,  Jinsheng Chen,  Kenneth J Wilson,  Shelley K Ballentine,  Renee L Desjarlais,  Carsten Schubert,  Carl S Crysler,  Yanmin Chen,  Christopher J Molloy,  Margery A Chaikin,  Carl L Manthey,  Mark R Player,  Bruce E Tomczuk,  Carl R Illig
Affiliations

Affiliation

  • 1 Johnson & Johnson Pharmaceutical Research & Development, Welsh & McKean Roads, Spring House, PA 19477, USA.
PMID: 18495479 DOI: 10.1016/j.bmcl.2008.04.059
Abstract

An anti-inflammatory 1,2,4-phenylenetriamine-containing series of FMS inhibitors with a potential to form reactive metabolites was transformed into a series with equivalent potency by incorporation of carbon-based replacement groups. Structure-based modeling provided the framework to efficiently effect this transformation and restore potencies to previous levels. This optimization removed a risk factor for potential idiosyncratic drug reactions.

Figures
Products